How we are engineering bacteria to eat cancer

medicalxpress - Modern medicine has made significant advances in cancer treatments over the decades. But all cancer therapies still face one critical challenge: how to target cancers without damaging healthy cells.

AI Summary: Researchers engineered bacteria that selectively attack and consume tumor tissue in preclinical models, demonstrating promising tumor control and a novel mechanism to deliver anti‑cancer effects. Significant questions remain about safety, immune responses and delivery in humans, so while the “bacteria that eat cancer” headline is delightful, translation to patients will require cautious, rigorous steps.

#pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch #clinicaltrials #genetics

5 days / medicalxpress


Back to Top / Sun, July 19, 2026, 10:21 pm / permalink 27329 / 2 stories in 19 hrs /




Related Stories


Daraxonrasib shows encouraging activity in NRAS-driven melanoma patients / 2 days

Rogaratinib shows activity in SDH‑deficient GIST phase 2 trial / 7 wks

Genetic clues explain tagraxofusp resistance in rare leukemia (BPDCN) / 9 days

Adjuvant selpercatinib sharply cuts recurrence in RET‑fusion lung cancer / 6 wks

CRISPR CD33‑deleted allogeneic transplant shows early AML promise / 2 months

Single‑cycle pembrolizumab yields striking responses in dMMR colon cancer / 2 months

EMERALD‑3 tests tremelimumab/durvalumab combos for embolisation‑eligible HCC / 16 days

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Price Transparency, Healthcare Finance, Infant Health, Genetics and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.